IL-17, an important pro-inflammatory cytokine, has been shown to promote proliferation, invasion, and metastasis of BC cells and is significantly associated with poor prognosis in patients with BC (Allaoui et al., 2017). This evidence concerns the gene IL17A and breast cancer.